Literature DB >> 23700092

Adoptive T-cell transfer for refractory viral infections with cytomegalovirus, Epstein-Barr virus or adenovirus after allogeneic stem cell transplantation.

J Feucht1, L Joachim, P Lang, T Feuchtinger.   

Abstract

Viral infections after allogeneic stem cell transplantation (SCT) are an important cause of morbidity and mortality as SCT can expose patients to a transient state of combined immunodeficieny. Most viral infections after SCT are caused by the endogenous reactivation of persistent pathogens such as adenovirus (ADV), cytomegalovirus (CMV), and Epstein-Barr-virus (EBV). The control of these infections will ultimately depend on the restoration of adequate T-cell immunity. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Year:  2013        PMID： 23700092     DOI： 10.1055/s-0033-1333749

Source DB:  PubMed          Journal:  Klin Padiatr        ISSN： 0300-8630            Impact factor:   1.349


  8 in total

Review 1.  Immunotherapy for opportunistic infections: Current status and future perspectives.

Authors:  Shigeo Fuji; Jürgen Löffler; Hermann Einsele; Markus Kapp
Journal:  Virulence       Date:  2016-07-06       Impact factor: 5.882

Review 2.  Virus-Specific T Cells: Current and Future Use in Primary Immunodeficiency Disorders.

Authors:  Katherine M Harris; Blachy J Davila; Catherine M Bollard; Michael D Keller
Journal:  J Allergy Clin Immunol Pract       Date:  2018-12-21

Review 3.  Adoptive T Cell Immunotherapy for Patients with Primary Immunodeficiency Disorders.

Authors:  Lauren P McLaughlin; Catherine M Bollard; Michael Keller
Journal:  Curr Allergy Asthma Rep       Date:  2017-01       Impact factor: 4.919

4.  Rapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.

Authors:  Sabine Tischer; Christoph Priesner; Hans-Gert Heuft; Lilia Goudeva; Wolfgang Mende; Marc Barthold; Stephan Kloeß; Lubomir Arseniev; Krasimira Aleksandrova; Britta Maecker-Kolhoff; Rainer Blasczyk; Ulrike Koehl; Britta Eiz-Vesper
Journal:  J Transl Med       Date:  2014-12-16       Impact factor: 5.531

Review 5.  Recent advances in haploidentical hematopoietic stem cell transplantation using ex vivo T cell-depleted graft in children and adolescents.

Authors:  Ho Joon Im; Kyung-Nam Koh; Jong Jin Seo
Journal:  Blood Res       Date:  2016-03-25

Review 6.  Adoptive T Cell Therapy for Epstein-Barr Virus Complications in Patients With Primary Immunodeficiency Disorders.

Authors:  Lauren P McLaughlin; Catherine M Bollard; Michael D Keller
Journal:  Front Immunol       Date:  2018-03-19       Impact factor: 7.561

Review 7.  Role of Epstein-Barr Virus in the Pathogenesis of Head and Neck Cancers and Its Potential as an Immunotherapeutic Target.

Authors:  Queenie Fernandes; Maysaloun Merhi; Afsheen Raza; Varghese Philipose Inchakalody; Nassima Abdelouahab; Abdul Rehman Zar Gul; Shahab Uddin; Said Dermime
Journal:  Front Oncol       Date:  2018-07-06       Impact factor: 6.244

8.  High-intensity interval training in allogeneic adoptive T-cell immunotherapy - a big HIT?

Authors:  Nele Carolin Heinemann; Sabine Tischer-Zimmermann; Torge Christian Wittke; Julian Eigendorf; Arno Kerling; Theodor Framke; Anette Melk; Hans-Gert Heuft; Rainer Blasczyk; Britta Maecker-Kolhoff; Britta Eiz-Vesper
Journal:  J Transl Med       Date:  2020-04-01       Impact factor: 5.531
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.